RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration

Amyotrophic Lateral Sclerosis (ALS) is an adult onset neurodegenerative disease, which is universally fatal. While the causes of this devastating disease are poorly understood, recent advances have implicated RNA-binding proteins (RBPs) that contain predicted prion domains as a major culprit. Specif...

Full description

Saved in:
Bibliographic Details
Main Authors: Scott E. Ugras, James Shorter
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Neurology Research International
Online Access:http://dx.doi.org/10.1155/2012/432780
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565657217007616
author Scott E. Ugras
James Shorter
author_facet Scott E. Ugras
James Shorter
author_sort Scott E. Ugras
collection DOAJ
description Amyotrophic Lateral Sclerosis (ALS) is an adult onset neurodegenerative disease, which is universally fatal. While the causes of this devastating disease are poorly understood, recent advances have implicated RNA-binding proteins (RBPs) that contain predicted prion domains as a major culprit. Specifically, mutations in the RBPs TDP-43 and FUS can cause ALS. Cytoplasmic mislocalization and inclusion formation are common pathological features of TDP-43 and FUS proteinopathies. Though these RBPs share striking pathological and structural similarities, considerable evidence suggests that the ALS-linked mutations in TDP-43 and FUS can cause disease by disparate mechanisms. In a recent study, Couthouis et al. screened for protein candidates that were also involved in RNA processing, contained a predicted prion domain, shared other phenotypic similarities with TDP-43 and FUS, and identified TAF15 as a putative ALS gene. Subsequent sequencing of ALS patients successfully identified ALS-linked mutations in TAF15 that were largely absent in control populations. This study underscores the important role that perturbations in RNA metabolism might play in neurodegeneration, and it raises the possibility that future studies will identify other RBPs with critical roles in neurodegenerative disease.
format Article
id doaj-art-875a39e7bdca48c892bdc9200d69fafa
institution Kabale University
issn 2090-1852
2090-1860
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Neurology Research International
spelling doaj-art-875a39e7bdca48c892bdc9200d69fafa2025-02-03T01:06:57ZengWileyNeurology Research International2090-18522090-18602012-01-01201210.1155/2012/432780432780RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and NeurodegenerationScott E. Ugras0James Shorter1Biochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USABiochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAAmyotrophic Lateral Sclerosis (ALS) is an adult onset neurodegenerative disease, which is universally fatal. While the causes of this devastating disease are poorly understood, recent advances have implicated RNA-binding proteins (RBPs) that contain predicted prion domains as a major culprit. Specifically, mutations in the RBPs TDP-43 and FUS can cause ALS. Cytoplasmic mislocalization and inclusion formation are common pathological features of TDP-43 and FUS proteinopathies. Though these RBPs share striking pathological and structural similarities, considerable evidence suggests that the ALS-linked mutations in TDP-43 and FUS can cause disease by disparate mechanisms. In a recent study, Couthouis et al. screened for protein candidates that were also involved in RNA processing, contained a predicted prion domain, shared other phenotypic similarities with TDP-43 and FUS, and identified TAF15 as a putative ALS gene. Subsequent sequencing of ALS patients successfully identified ALS-linked mutations in TAF15 that were largely absent in control populations. This study underscores the important role that perturbations in RNA metabolism might play in neurodegeneration, and it raises the possibility that future studies will identify other RBPs with critical roles in neurodegenerative disease.http://dx.doi.org/10.1155/2012/432780
spellingShingle Scott E. Ugras
James Shorter
RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
Neurology Research International
title RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
title_full RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
title_fullStr RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
title_full_unstemmed RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
title_short RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
title_sort rna binding proteins in amyotrophic lateral sclerosis and neurodegeneration
url http://dx.doi.org/10.1155/2012/432780
work_keys_str_mv AT scotteugras rnabindingproteinsinamyotrophiclateralsclerosisandneurodegeneration
AT jamesshorter rnabindingproteinsinamyotrophiclateralsclerosisandneurodegeneration